Your browser doesn't support javascript.
Immune Modulation in Sepsis, ARDS, and Covid-19 - The Road Traveled and the Road Ahead
NEJM Evidence ; 1(11):1-16, 2022.
Article in English | CINAHL | ID: covidwho-2096905
ABSTRACT
Leligdowicz et al. consider the history and future of immunomodulating therapies in sepsis and ARDS, including ARDS due to Covid-19, and remark on the larger challenge of clinical research on therapies for syndromes with profound clinical and biologic heterogeneity.

Full text: Available Collection: Databases of international organizations Database: CINAHL Language: English Journal: NEJM Evidence Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: CINAHL Language: English Journal: NEJM Evidence Year: 2022 Document Type: Article